SGLN yields 2000000.00% · JNJ yields 2.13%● Live data
📍 SGLN pulled ahead of the other in Year 1
Combined, SGLN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SGLN + JNJ for your $10,000?
Surgline International, Inc. sources and sells medical and surgical products. It offers a range of surgical instruments, including scissors, forceps, basket punches, reamers, and pulse lavages. The company also provides surgical sets, such as hand and foot, and hips and small fragments; spine products consisting of ALIF systems, anterior cervical plates, PLIF systems, TLIF systems, cervical PEEK IBFDs, and pedicle screw systems; drill system and power tools comprising cordless and pneumatic drills, chucks, sleeves, saws, hoes, charges, and batteries. In addition, it offers emergency removal devices for broken screws and implant removal; a range of endoscopes; surgical burs and blades; and medical, surgical, and dental disposables. The company sells its products under the Surg brand. It serves acute care hospitals, ambulatory surgery centers, physicians, dentists, urgent care centers, and insurers, as well as others. The company was formerly known as China Nuvo Solar Energy, Inc. and changed its name to Surgline International, Inc. in October 2011. Surgline International, Inc. is based in Newport Beach, California.
Full SGLN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.